| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 8 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | Canada | 4 | |
| #4 | Australia | 3 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Measuring microorganism processes | |
| #2 | Medical preparations | |
| #3 | Unspecified technologies | |
| #4 | Therapeutic chemical compounds | |
| #5 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Risinger Carl | 9 |
| #2 | Andersson Maria Kristina | 9 |
| #3 | Lewander Tommy | 9 |
| #4 | Oliasson Erik | 6 |
| #5 | Bansal Aruna | 5 |
| #6 | Olaisson Erik | 3 |
| #7 | Wilson Scott Geoffrey | 3 |
| #8 | Reed Peter | 3 |
| #9 | Sallstrom Eva Gunvor Kristina | 3 |
| #10 | Zabarovsky Eugene | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO02072604A2 | Genes and polymorphisms associated with cardiovascular disease and their use | |
| AU2002246691A1 | Nucleic acid encoding ion transporter component protein | |
| CA2420322A1 | Detection of cyp2d6 polymorphisms | |
| AU3938799A | Polymorphism in a nitric oxide synthase gene | |
| EP1394273A1 | Diagnostic method and apparatus | |
| EP0883694A1 | Determination of collagen genotype |